HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Gwee, P.-C. Articles by Lee, C. G.L. Search for Related Content PubMed PubMed Citation Articles by Gwee, P.-C. Articles by Lee, C. G.L. Related Collections Molecular Diagnostics and Genetics

Simultaneous Genotyping of Seven Single-Nucleotide Polymorphisms in the MDR1 Gene by Single-Tube Multiplex Minisequencing

Departments of
¹ Biochemistry,
³ Pharmacology, and
⁴ Pediatrics, National University of Singapore, Singapore 117597, Singapore
² Division of Medical Sciences, National Cancer Center, Singapore 169610, Singapore
Departments of
⁵ Pediatrics and
⁶ Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205

^aaddress correspondence to this author at: Division of Medical Sciences, National Cancer Center, Level 6, Lab 5, 11 Hospital Dr., Singapore 169610, Singapore; fax 65-6224-1778, e-mail bchleec@nus.edu.sg

The first 300 words of the full text of this article appear below.

Responses to different drugs can vary widely among different individuals as a result of genetic variations in drug-metabolizing enzymes, transporters, receptors, and/or other cofactors. The multidrug resistance 1 (MDR1) transporter, a well-characterized member of the ATP-binding cassette superfamily, was shown to efflux a wide variety of structurally and functionally unrelated drugs, including anticancer, antiarrhythmic, antidepressant, antipsychotic, and antiviral agents. The pharmacogenetics of the MDR1 multidrug transporter have recently received much scientific attention. Several single-nucleotide polymorphisms (SNPs) have been identified in the MDR1 gene; some occur only in specific ethnic groups, whereas others occur in all ethnic groups but at significantly different allele frequencies among the different races [see Ref. (1) and references therein]. Nonetheless, the functional significance of these SNPs remains unclear. Various functional associations, some paradoxical, have been observed between the synonymous SNP (exon 26 3435CT) and MDR1 protein expression and plasma drug concentrations (2)(3)(4)(5), drug-induced side effects (6), and drug response (7). The SNP exon 26 3435T allele has been associated with lower MDR1 expression in the duodenum (2), leukocytes (5), and placental tissues (8), leading to lower rhodamine efflux (5) and increased plasma digoxin concentrations (2). In addition, early-onset Parkinson patients have higher frequency of the SNP exon 26 3435T allele compared with late-onset patients or unaffected controls (9). However, although this same allele has been associated with lower MDR1 expression in peripheral blood mononuclear cells and better response to HIV-1 drugs, it has also been associated with lower plasma concentrations of nelfinavir (7). Additionally, the SNP exon 26 3435T allele has been associated with an increased risk of nortriptyline-induced postural hypertension, although blood concentrations of nortriptyline in . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				Z. Wang, J. Wang, E. Tantoso, B. Wang, A. Y.P. Tai, L. L.P.J. Ooi, S. S. Chong, and C. G.L. Lee Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci Hum. Mol. Genet., June 1, 2007; 16(11): 1367 - 1380. [Abstract] [Full Text] [PDF]

				Z. Wang, B. Wang, K. Tang, E. J.D. Lee, S. S. Chong, and C. G.L. Lee A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection Hum. Mol. Genet., July 15, 2005; 14(14): 2075 - 2087. [Abstract] [Full Text] [PDF]

				E.-K. Tan, D. K.-Y. Chan, P.-W. Ng, J. Woo, Y. Y. Teo, K. Tang, L.-P. Wong, S. S. Chong, C. Tan, H. Shen, et al. Effect of MDR1 Haplotype on Risk of Parkinson Disease Arch Neurol, March 1, 2005; 62(3): 460 - 464. [Abstract] [Full Text] [PDF]

				A. M. Knaapen, H. B. Ketelslegers, R. W.H. Gottschalk, R. G.J.H. Janssen, A. D.C. Paulussen, H. J.M. Smeets, R. W.L. Godschalk, F. J. Van Schooten, J. C.S. Kleinjans, and J. H.M. Van Delft Simultaneous Genotyping of Nine Polymorphisms in Xenobiotic-Metabolizing Enzymes by Multiplex PCR Amplification and Single Base Extension Clin. Chem., September 1, 2004; 50(9): 1664 - 1668. [Full Text] [PDF]

				C G L Lee, K Tang, Y B Cheung, L P Wong, C Tan, H Shen, Y Zhao, R Pavanni, E J D Lee, M-C Wong, et al. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese J. Med. Genet., May 1, 2004; 41(5): e60 - e60. [Full Text] [PDF]

				K. Tang, L. P. Wong, E. J.D. Lee, S. S. Chong, and C. G.L. Lee Genomic evidence for recent positive selection at the human MDR1 gene locus Hum. Mol. Genet., April 15, 2004; 13(8): 783 - 797. [Abstract] [Full Text] [PDF]